W
Werner Hacke
Researcher at Heidelberg University
Publications - 688
Citations - 93115
Werner Hacke is an academic researcher from Heidelberg University. The author has contributed to research in topics: Stroke & Thrombolysis. The author has an hindex of 123, co-authored 656 publications receiving 84593 citations. Previous affiliations of Werner Hacke include University Hospital Heidelberg & Steklov Mathematical Institute.
Papers
More filters
Journal ArticleDOI
The relationship between CYP2C19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: the CHARISMA genetics study
Deepak L. Bhatt,Guillaume Paré,John W. Eikelboom,Katy L. Simonsen,Katy L. Simonsen,Eileen Emison,Keith A.A. Fox,Ph. Gabriel Steg,Ph. Gabriel Steg,Gilles Montalescot,Gilles Montalescot,Nihar Bhakta,Werner Hacke,Marcus Flather,Koon-Hou Mak,Patrice Cacoub,Mark A. Creager,Peter B. Berger,Steven R. Steinhubl,Gurunathan Murugesan,Shamir R. Mehta,Kandice Kottke-Marchant,A. Michael Lincoff,Eric J. Topol +23 more
TL;DR: No relationship was seen between CYP2C19 status and ischaemic outcomes in stable patients treated with clopidogrel, suggesting less anti-platelet response and a potential link with reduced bleeding complications.
Journal ArticleDOI
European Stroke Initiative (EUSI) recommendations for stroke management. The European Stroke Initiative Writing Committee.
TL;DR: The European Stroke Initiative (EUSI) has authorized the writing committee of the EUSI to create recommendations for stroke management covering all areas of stroke treatment, which are called recommendations rather than guidelines in order to underline the large amount of individual decision making.
Journal ArticleDOI
SPACE-2: A Missed Opportunity to Compare Carotid Endarterectomy, Carotid Stenting, and Best Medical Treatment in Patients with Asymptomatic Carotid Stenoses.
Hans-Henning Eckstein,Tilman Reiff,Peter A. Ringleb,Olav Jansen,Ulrich Mansmann,Werner Hacke +5 more
TL;DR: There were several potential reasons for the low recruitment rates into SPACE-2, including the ability for referring doctors to refer their patients directly for CEA or CAS outwith the trial, an inability to convince patients (who had come "mentally prepared" that an intervention was necessary) to accept BMT, and other economic constraints.
Journal ArticleDOI
European Strategies for Early Intervention in Stroke (Part 1 of 2)
TL;DR: Stroke is a major cause of death and disability in industrialized countries, but stroke awareness is still generally poor and treatment often ill-defined.
Journal ArticleDOI
Thrombolytic Therapy Within 3 to 6 Hours After Onset of Ischemic Stroke Useful or Harmful
TL;DR: It appears unjustified to limit thrombolytic therapy to 3 hours, and better methods for patient selection are required; in particular, newer MRI techniques, such as diffusion- and perfusion-weighted imaging, can play a key role.